Evidence map›Paper›PMID 16896927›Full record

ArticleHuman genetics2006

A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C > T).

Riddhish Shah, Carolyn K Hurley, Phillip E Posch

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Relationship Between anJournal of clinical medicine · 2025
    Article
  5. Review
  6. Article
  7. Role of Elevated Serum TGF-β1 and the Common PromoterMedicina (Kaunas, Lithuania) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Influence ofInternational journal of molecular sciences · 2022
    Article
  13. Tolerance Assessment ofAntioxidants (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Riddhish ShahDepartment of Oncology, Georgetown University Medical Center, Washington, DC 20007, USA.
Carolyn K Hurley
Phillip E Posch
Georgetown University · USGeorgetown University Medical Center · US

Funding

EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECTSC06RR014567 · NCRR · GEORGETOWN UNIVERSITY · PI PESTELL, RICHARD G · 1999 to 1999
–
NCRR NIH HHS C06 RR14567
6 · The paper itself

Abstract

Transforming growth factor beta1 (TGF-beta1) levels influence many cellular, immunologic and pathologic processes. Activator protein 1 (AP1) and hypoxia are key regulators of TGF-beta1 expression levels. The common TGFB1 promoter SNP c.-1347C > T (-509C-T, rs1800469) has been linked to a nearly twofold difference in plasma levels among individuals and with risk, progression, and outcome of numerous diseases. We demonstrate exclusive in vitro and in vivo recruitment of AP1 containing JunD to -1347C. This study also is the first to demonstrate hypoxia inducible factor 1 (HIF-1) binding to the TGFB1 promoter. HIF-1 was found to associate with both -1347C and -1347T and compete with AP1 for binding to -1347C. Reporter constructs demonstrate that expression differences between -1347C and -1347T are due to selective AP1 recruitment to the TGFB1 promoter. As AP1 is known to down-regulate transcription of other genes, we suggest that the molecular mechanism for the difference in TGF-beta1 plasma levels linked to -1347 is due to transcriptional suppression by AP1 binding to -1347C. These data should aid in our understanding of the association of the -1347 SNP with the pathogenesis of certain TGF-beta1-related diseases.

Indexed as

Gene Expression RegulationPolymorphism, Single NucleotideBinding, CompetitiveBinding SitesCell LineCell Line, TumorChromatin ImmunoprecipitationElectrophoretic Mobility Shift AssayHumansHypoxia-Inducible Factor 1LuciferasesOligonucleotide ProbesPromoter Regions, GeneticProtein BindingProto-Oncogene Proteins c-junRecombinant Fusion ProteinsHypoxia-Inducible Factor 1LuciferasesOligonucleotide ProbesProto-Oncogene Proteins c-junRecombinant Fusion ProteinsTranscription Factor AP-1Transforming Growth Factor beta1

Identifiers

PMID16896927
OpenAlexW2053244132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.